A Tocopheryl Acid Succinate, d-Alpha CEP of the European Pharmacopoeia monograph is often referred to as a Tocopheryl Acid Succinate, d-Alpha Certificate of Suitability (COS). The purpose of a Tocopheryl Acid Succinate, d-Alpha CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tocopheryl Acid Succinate, d-Alpha EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tocopheryl Acid Succinate, d-Alpha to their clients by showing that a Tocopheryl Acid Succinate, d-Alpha CEP has been issued for it. The manufacturer submits a Tocopheryl Acid Succinate, d-Alpha CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tocopheryl Acid Succinate, d-Alpha CEP holder for the record. Additionally, the data presented in the Tocopheryl Acid Succinate, d-Alpha CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tocopheryl Acid Succinate, d-Alpha DMF.
A Tocopheryl Acid Succinate, d-Alpha CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tocopheryl Acid Succinate, d-Alpha CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tocopheryl Acid Succinate, d-Alpha suppliers with CEP (COS) on PharmaCompass.